EuBiologics disclosed Tuesday that it has signed a contract with UNICEF to supply its oral cholera vaccine, Euvichol-S.
The contract is valued at 10.1 billion won ($6.71 million), equivalent to 6.77 percent of the company's 2025 sales.
The contract runs through Sept. 12.
jiyoon436@heraldcorp.com
